PTGX vs. ATRO
PTGX (Protagonist Therapeutics Inc) and ATRO (Astronics Corporation) are both stocks. PTGX operates in Biotechnology (Healthcare), while ATRO operates in Aerospace & Defense (Industrials). Over the past 5 years, PTGX returned 21.60%/yr vs 41.67%/yr for ATRO. At a 0.23 correlation, their price movements are largely independent.
Performance
PTGX vs. ATRO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PTGX achieves a 31.70% return, which is significantly lower than ATRO's 89.08% return.
PTGX
- 1D
- 1.92%
- 1M
- 15.97%
- YTD
- 31.70%
- 6M
- 31.60%
- 1Y
- 115.65%
- 3Y*
- 60.91%
- 5Y*
- 21.60%
- 10Y*
- —
ATRO
- 1D
- 1.60%
- 1M
- 26.83%
- YTD
- 89.08%
- 6M
- 84.09%
- 1Y
- 210.12%
- 3Y*
- 77.18%
- 5Y*
- 41.67%
- 10Y*
- 13.83%
PTGX vs. ATRO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PTGX Protagonist Therapeutics Inc | 31.70% | 126.27% | 68.34% | 110.17% | -68.10% | 69.64% | 185.96% | 4.75% | -67.64% | -5.41% |
ATRO Astronics Corporation | 89.08% | 239.85% | -8.38% | 69.13% | -14.17% | -9.30% | -52.67% | -8.21% | -13.21% | 22.55% |
Correlation
The correlation between PTGX and ATRO is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.29 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.29 |
Correlation (All Time) Calculated using the full available price history since Aug 11, 2016 | 0.23 |
Fundamentals
PTGX:
$8.11B
ATRO:
$3.13B
PTGX:
-$1.76
ATRO:
$1.22
PTGX:
424.74
ATRO:
3.43
PTGX:
12.37
ATRO:
19.35
PTGX:
$17.70M
ATRO:
$886.81M
PTGX:
$17.32M
ATRO:
$272.44M
PTGX:
-$127.71M
ATRO:
$74.47M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PTGX vs. ATRO — Risk / Return Rank
PTGX
ATRO
PTGX vs. ATRO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Protagonist Therapeutics Inc (PTGX) and Astronics Corporation (ATRO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PTGX | ATRO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.51 | ||
| Sortino ratioReturn per unit of downside risk | -0.67 | ||
| Omega ratioGain probability vs. loss probability | 1.41 | 1.53 | -0.12 |
| Calmar ratioReturn relative to maximum drawdown | 7.10 | 9.04 | -1.94 |
| Martin ratioReturn relative to average drawdown | 16.26 | 31.21 | -14.95 |
Loading charts...
Drawdowns
PTGX vs. ATRO - Drawdown Comparison
The maximum PTGX drawdown since its inception was -85.79%, roughly equal to the maximum ATRO drawdown of -90.12%. Use the drawdown chart below to compare losses from any high point for PTGX and ATRO.
Loading charts...
Drawdown Indicators
| PTGX | ATRO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -85.79% | -90.12% | +4.33% |
Max Drawdown (1Y)Largest decline over 1 year | -16.38% | -23.39% | +7.01% |
Max Drawdown (3Y)Largest decline over 3 years | -51.13% | -34.89% | -16.24% |
Max Drawdown (5Y)Largest decline over 5 years | -85.79% | -60.47% | -25.32% |
Max Drawdown (10Y)Largest decline over 10 years | — | -85.52% | — |
Current DrawdownCurrent decline from peak | 0.00% | 0.00% | 0.00% |
Average DrawdownAverage peak-to-trough decline | -40.59% | -38.06% | -2.53% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.14% | 6.76% | +0.38% |
Volatility
PTGX vs. ATRO - Volatility Comparison
The current volatility for Protagonist Therapeutics Inc (PTGX) is 15.00%, while Astronics Corporation (ATRO) has a volatility of 19.02%. This indicates that PTGX experiences smaller price fluctuations and is considered to be less risky than ATRO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PTGX | ATRO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.00% | 19.02% | -4.02% |
Volatility (6M)Calculated over the trailing 6-month period | 29.56% | 39.42% | -9.86% |
Volatility (1Y)Calculated over the trailing 1-year period | 51.19% | 55.91% | -4.72% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 85.15% | 55.12% | +30.03% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 90.70% | 56.92% | +33.78% |
Dividends
PTGX vs. ATRO - Dividend Comparison
Neither PTGX nor ATRO has paid dividends to shareholders.
Financials
PTGX vs. ATRO - Financials Comparison
This section allows you to compare key financial metrics between Protagonist Therapeutics Inc and Astronics Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
PTGX and ATRO have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ATRO has higher volatility (19.02%) compared to PTGX (15.00%). In terms of maximum drawdown, PTGX dropped -85.79% vs ATRO's -90.12%.
ATRO currently has the higher Sharpe Ratio (3.79 vs 2.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PTGX and ATRO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer